Paul Hamelin serves as Executive at SAVIENT PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Paul Hamelin has executed 53 insider transactions totaling $1.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 15, 2007 involved receiving (via award) 13,860 shares valued at $0.
Paul Hamelin currently holds 124,765 shares of SAVIENT PHARMACEUTICALS INC (SVNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Hamelin has been a net seller of SVNT stock. They have purchased $0 and sold $1.3M worth of shares.
Paul Hamelin's most recent insider trade was on Feb 15, 2007, when they sold 13,860 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 23, 2006 | SVNT | $0 | Award | 12,000 | $N/A | Discretionary |